FDA Gives Seno Medical Approval for Opto-Acoustic Breast Imaging System
January 20, 2021
Seno’s Imagio® breast imaging system can help providers distinguish, in real-time, between benign and malignant breast lesions.
January 20, 2021
The number of CT scans corresponds to an increase in risk of hematologic malignant neoplasms, especially in children under age 16.
January 20, 2021
Seno’s Imagio® breast imaging system can help providers distinguish, in real-time, between benign and malignant breast lesions.